Vale SA
VALE
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
KB Home
KBH
Lennar Corp
LEN
US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 1.605
- -0.065-3.89%
Trading Mar 28 13:34 ET
90.94MMarket Cap-1.26P/E (TTM)
1.650High1.550Low787.52KVolume1.650Open1.670Pre Close1.25MTurnover2.02%Turnover RatioLossP/E (Static)56.66MShares7.66052wk High1.09P/B62.57MFloat Cap1.54552wk Low--Dividend TTM38.98MShs Float46.250Historical High--Div YieldTTM5.99%Amplitude1.180Historical Low1.591Avg Price1Lot Size
About Black Diamond Therapeutics Company
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees24
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848
Company Executives
- Name
- Position
- Salary
- Dr. Mark A. Velleca, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.95M
- Melanie Morrison
- Chief Development Officer
- --
- Elizabeth L. Montgomery
- Chief People Officer
- --
- Elizabeth Buck, PhD
- Chief Scientific Officer
- --
- Sergey Yurasov, M.D.,Pd.D
- Chief Medical Officer
- 1.23M
- Brent Hatzis-Schoch, Esq.
- Chief Operating Officer and General Counsel
- --
- Erika Jones
- Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- --
- Shannon Campbell, PhD
- Independent Director
- --
- Dr. Samarth Kulkarni, PhD
- Lead Independent Director
- 59.35K
- Dr. Prakash Raman, PhD
- Independent Director
- --
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 109.35K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 75.35K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 68.14K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.